(Q53561310)
Statements
Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma. (English)
Lee M Krug
Robert T Heelan
Ennapadam Venkatraman
F M Sirotnak
1 April 2007
2
4
317-320